Sensibilité d'une analyse coût-bénéfice - Enseignements pour l'évaluation des projets d'atténuation des inondations

National audienceCost-Benefit Analysis based on the damage avoided approach gives rise to several synthetic indicators measuring either the flood exposure of an area (mean annual damage), or the interest to conduct a flood prevention policy (mean annual damage avoided, net present value). Those indicators are the outcome of a combination of hydrological, hydraulic, geographic and economic models. Although it is recommended to study the precision of these indicators, this is rarely done in practice, as the combined models which are needed are relatively complex. In this article, we present an approach which is based on Monte-Carlo analysis, and discuss the insights which can be drawn from it on the validity of the indicators.L'analyse coût-bénéfice basée sur la simulation des dommages évités permet d'obtenir des indicateurs synthétiques sur l'exposition d'un territoire aux inondations (les dommages moyens annualisés), ainsi que l'intérêt ou non de mener une politique de prévention des inondations (les dommages évités moyens annualisés, la valeur actuelle nette). Ces indicateurs sont issus de la combinaison de modélisations hydrologiques, hydrauliques, géographiques et économiques d'un territoire. Bien qu'il soir recommandé d'en étudier la précision et la sensibilité, cette étape n'est que très rarement effectuée en pratique, notamment du fait de la complexité de la combinaison des différents modèles mobilisés. Dans cet article, au travers d'un exemple, nous proposons une approche reposant sur la technique de Monte-Carlo et analysons les enseignements concernant la validité des indicateurs

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in elderly people. AD is characterized by a progressive cognitive decline and it is neuropathologically defined by two hallmarks: extracellular deposits of aggregated β-amyloid (Aβ) peptides and intraneuronal fibrillar aggregates of hyper- and abnormally phosphorylated Tau proteins. AD results from multiple genetic and environmental risk factors. Epidemiological studies reported beneficial effects of caffeine, a non-selective adenosine receptors antagonist. In the present review, we discuss the impact of caffeine and of adenosinergic system modulation on AD, in terms of pathology and therapeutics

Structural basis of envelope and phase intrinsic coupling modes in the cerebral cortex

Intrinsic coupling modes (ICMs) can be observed in ongoing brain activity at multiple spatial and temporal scales. Two families of ICMs can be distinguished: phase and envelope ICMs. The principles that shape these ICMs remain partly elusive, in particular their relation to the underlying brain structure. Here we explored structure-function relationships in the ferret brain between ICMs quantified from ongoing brain activity recorded with chronically implanted micro-ECoG arrays and structural connectivity (SC) obtained from high-resolution diffusion MRI tractography. Large-scale computational models were used to explore the ability to predict both types of ICMs. Importantly, all investigations were conducted with ICM measures that are sensitive or insensitive to volume conduction effects. The results show that both types of ICMs are significantly related to SC, except for phase ICMs when using measures removing zero-lag coupling. The correlation between SC and ICMs increases with increasing frequency which is accompanied by reduced delays. Computational models produced results that were highly dependent on the specific parameter settings. The most consistent predictions were derived from measures solely based on SC. Overall, the results demonstrate that patterns of cortical functional coupling as reflected in both phase and envelope ICMs are both related, albeit to different degrees, to the underlying structural connectivity in the cerebral cortex.This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB 936 - 178316478 - A1 (C.C.H.), A2 (A.K.E.), and Z3 (C.C.H. and A.M.), SPP1665 - 220176618 - EN533/13-1 (A.K.E.), SPP2041 - 313856816 - HI1286/6-1 (C.C.H.) and EN533/15-1 (A.K.E.), from the European Unions Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreements 785907 and 945539 (Human Brain Project SGA2 and SGA3, C.C.H.), and from the 2015 FLAG-ERA Joint Transnational Call for project FIIND - ANR-15-HBPR-0005 (R.T.).Peer reviewe

Imaging of central nervous system by MALDI mass spectrometry

Ces dernières années, l’imagerie par spectrométrie de masse MALDI s’est révélée être un outil puissant pour la recherche de biomarqueurs puisqu’elle permet d’effectuer l’analyse d’un large panel de composés endogènes et exogènes dans des coupes de tissu. Des développements restent néanmoins à faire pour l’amélioration de la détection des molécules. La préparation de l’échantillon, incluant les traitements chimiques et le dépôt de la matrice, est dépendante du tissu et des molécules d’intérêt et influence la qualité des spectres et des images. D’autre part, les outils bioinformatiques tels que les analyses multi variées apportent des informations sur les marqueurs en fonction des phénotypes. Ces étapes sont donc cruciales pour les applications de l’imagerie dans le domaine de la biologie. Tout d’abord, nous nous sommes donc axés sur le développement de nouvelles matrices adaptées à l’imagerie MALDI telles que les matrices ioniques. Ensuite, ces développements ont été appliqués au modèle invertébré sangsue médicinale, aux stades embryonnaires et adultes, afin de comparer les mécanismes biologiques intervenant lors de l’édification du système nerveux central et de la régénération nerveuse après lésion de ce système. Enfin, des études sur des atteintes neurologiques ont été entreprises afin de comprendre les facteurs clés impliqués dans la balance régénération/dégénérescence. Ainsi, les études des échantillons d’hippocampes humains ont révélés l’existence de protéines associées à une distribution particulière correspondant à des couches des neurones anormalement présents dans l’hippocampe des patients épileptiques.In recent years, MALDI mass spectrometric imaging has proved to be a powerful tool for biomarker research. This technology allows the analysis of a wide range of endogenous and exogenous compounds in tissue sections. Many developments need to be undertaken to improve the detection of molecules. The sample preparation, including chemical treatment and deposition of the matrix, is dependent on the tissue and molecules of interest and influences the quality of spectra and images. In addition, the bioinformatics tools such as multivariate analysis provide informations on the markers according to phenotypes. These steps are crucial for imaging applications in the field of biology. First of all, we focused on the development of new matrices suitable for MALDI imaging such as ionic matrices. Secondly, these developments have been applied to the invertebrate model, the medicinal leech, at embryonic and adult stages, to compare the biological mechanisms involved in the establishment of the central nervous system and nerve regeneration after injury of this system. Finally, studies of neurological damage have been undertaken to understand the key factors involved in the balance regeneration/degeneration. Thus, studies of human hippocampi samples have revealed the existence of proteins associated with a particular distribution corresponding to layers of neurons abnormally present in the hippocampus of epileptic patients

RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis

International audienceThe therapeutic use of RhoA inhibitors (RhoAi) has been experimentally tested in spinal cord injury (SCI). In order to decipher the underlying molecular mechanisms involved in such a process, an in vitro neuroproteomic-systems biology platform was developed in which the pan-proteomic profile of the dorsal root ganglia (DRG) cell line ND7/23 DRG was assessed in a large array of culture conditions using RhoAi and/or conditioned media obtained from SCI ex vivo derived spinal cord slices. A fine mapping of the spatio-temporal molecular events of the RhoAi treatment in SCI was performed. The data obtained allow a better understanding of regeneration/degeneration induced above and below the lesion site. Results notably showed a time-dependent alteration of the transcription factors profile along with the synthesis of growth cone-related factors (receptors, ligands, and signaling pathways) in RhoAi treated DRG cells. Furthermore, we assessed in a rat SCI model the in vivo impact of RhoAi treatment administered in situ via alginate scaffold that was combined with FK506 delivery. The improved recovery of locomotion was detected only at the early postinjury time points, whereas after overall survival a dramatic increase of synaptic contacts on outgrowing neurites in affected segments was observed. We validate these results by in vivo proteomic studies along the spinal cord segments from tissue and secreted media analyses, confirming the increase of the synaptogenesis expression factors under RhoAi treatment. Taken together, we demonstrate that RhoAi treatment seems to be useful to stimulate neurite outgrowth in both in vitro as well in vivo environments. However, for in vivo experiments there is a need for sustained delivery regiment to facilitate axon regeneration and promote synaptic reconnections with appropriate target neurons also at chronic phase, which in turn may lead to higher assumption for functional improvement

A new paradigm for high-sensitivity 19 F magnetic resonance imaging of perfluorooctylbromide

International audienceIn the present work, the NMR properties of perfluorooctylbromide are revisited to derive a high-sensitivity fluorine MRI strategy. It is shown that the harmful effects of J-coupling can be eliminated by carefully choosing the bandwidth of the 180 degrees pulses in a spin-echo sequence. The T(2) of the CF(3) resonance of the molecule is measured using a multispin-echo sequence and shown to dramatically depend on the interpulse delay. Following these observations, an optimized multispin-echo imaging sequence is derived and compared with short TE/pulse repetition time gradient echo and chemical shift imaging sequences. The unparalleled sensitivity yielded by the multispin-echo sequence is promising for future applications, in particular for targeted contrast agents such as perfluorooctylbromide nanoparticles

Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair

International audienceSpinal cord injury (SCI) represents a major debilitating health issue with a direct socioeconomic burden on the public and private sectors worldwide. Although several studies have been conducted to identify the molecular progression of injury sequel due from the lesion site, still the exact underlying mechanisms and pathways of injury development have not been fully elucidated. In this work, based on OMICs, 3D matrix-assisted laser desorption ionization (MALDI) imaging, cytokines arrays, confocal imaging we established for the first time that molecular and cellular processes occurring after SCI are altered between the lesion proximity, i.e. rostral and caudal segments nearby the lesion (R1-C1) whereas segments distant from R1-C1, i.e. R2-C2 and R3-C3 levels coexpressed factors implicated in neurogenesis. Delay in T regulators recruitment between R1 and C1 favor discrepancies between the two segments. This is also reinforced by presence of neurites outgrowth inhibitors in C1, absent in R1. Moreover, the presence of immunoglobulins (IgGs) in neurons at the lesion site at 3 days, validated by mass spectrometry, may present additional factor that contributes to limited regeneration. Treatment in vivo with anti-CD20 one hour after SCI did not improve locomotor function and decrease IgG expression. These results open the door of a novel view of the SCI treatment by considering the C1 as the therapeutic target